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Supplementary Methods

Cell Culture
Mouse embryonic fibroblasts (STO cell line) were maintained in Dulbecco's Modified Eagles Media (DMEM), supplemented with 100 units/mL Penn/Strep, 1X L-Glutamine, 1X Nonessential amino acids, and 15% fetal bovine serum (FBS). All media components were obtained from GIBCO and were filter sterilized (0.2 µm) prior to use. Cells were routinely passaged with 0.05% trypsin/EDTA when 80% confluent and seeded at a cell density of 2x10 6 /10 cm plate.
Cell count and viability were obtained using a Biorad TC10 Automated Cell Counter.
Cell Lysis, Membrane Protein Preparation, and Protein Digestion
Approximately 1x10 8 cells were washed three times with Phosphate Buffered Saline (PBS) w/ 0.1% FBS and then detached using Enzyme Free Cell Dissociation Solution (Millipore) for 30 min at room temperature. The cells were collected by centrifugation at 500 x g at 4°C for 5 min then resuspended in hypotonic lysis buffer (10 mM Tris pH 7.5 (Quality Biological), 0.5mM MgCl 2 (Quality Biological)) and placed on ice for 10 minutes to swell. The cells were homogenized using a gentleMACS™ Dissociator (Miltenyi Biotec) and the homogenate was centrifuged at 800 x g at 4°C for 10 min to remove nuclei and debris. The supernatant was combined with an equal volume of membrane prep buffer (280 mM Sucrose, 50 mM MES, 450 mM NaCl, 10 mM MgCl 2 ) and divided evenly (±.001 g) into six Ultra-clear ultracentrifuge tubes (Beckman) and centrifuged overnight at 210,000 x g at 4 o C to pellet the mixed membrane fraction. This preparation was repeated such that twelve sets of six tubes were obtained, wherein all tubes within a single set contained an equivalent amount of protein to allow for comparison of conditions across the tubes within a single set. Each comparison set was performed in duplicate.
Mass Spectrometry
Samples were analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) on an LTQ linear ion trap (Thermo) as well equipped with a Surveyor nano HPLC (Thermo). Peptides were resuspended in 120 µL mobile phase A (5% acetonitrile, 0.1% formic acid) and 2 µL were loaded onto an IntegraFrit ProteoPep™ II column (75 µm ID, 15 cm, C18, implementing PeptideProphet 13 and ProteinProphet 14 algorithms as described in the supplement. Database search parameters were as follows: full enzyme digest using trypsin (after Lys or Arg) with up to two missed cleavages; monoisotopic precursor mass range of 400-4500 amu; carbamidomethylation (Cys) as a static modification and oxidation (Met) allowed as a differential modification; peptide mass tolerance was set to 1.5 amu; fragment mass type as average. All data from technical replicate analyses of each sample were merged into a single ProteinProphet result file. Default parameters for PeptideProphet and ProteinProphet were used and consistent among all samples. The ProteinProphet interact-prot.xml result files were imported into ProteinCenter (Thermo) and filtered to contain only proteins corresponding to a false discovery rate (FDR) ≤1.5% (FDR calculated by ProteinProphet). Within ProteinCenter, redundancy was removed by grouping indistinguishable proteins to collapse any proteins identified by the same peptide sequence into a single entry. The percent sequence coverage, number of predicted transmembrane domains as calculated by TMAP 15 , and grand average of hydropathy (GRAVY) 16 scores were provided by ProteinCenter. 
